Makers Laboratories Limited (MAKERSL.BO)
INR 172.0
(-0.52%)
INR 172.0
(-0.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 25.81 Million INR | -81.5% |
| 2022 | 48.78 Million INR | -73.62% |
| 2021 | 214.06 Million INR | 122.85% |
| 2020 | 89.24 Million INR | 195.95% |
| 2019 | 29.41 Million INR | -36.38% |
| 2018 | 47.76 Million INR | -20.79% |
| 2017 | 61.66 Million INR | 9.76% |
| 2016 | 66.87 Million INR | 7.1% |
| 2015 | 51.09 Million INR | 10.11% |
| 2014 | 46.05 Million INR | 94.12% |
| 2013 | 25.89 Million INR | -42.17% |
| 2012 | 54.39 Million INR | 179.27% |
| 2011 | 16.11 Million INR | -76.8% |
| 2010 | 67.69 Million INR | 30.65% |
| 2009 | 52.79 Million INR | 23.96% |
| 2008 | 42.59 Million INR | 67.05% |
| 2007 | 25.49 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 18.09 Million INR | 0.96% |
| 2024 Q2 | 128.14 Million INR | 885.71% |
| 2023 Q3 | 2.01 Million INR | -66.78% |
| 2023 Q1 | 1.16 Million INR | -94.38% |
| 2023 FY | - INR | -81.5% |
| 2023 Q2 | 6.06 Million INR | 421.13% |
| 2023 Q4 | 8.6 Million INR | 327.0% |
| 2022 Q3 | 924 Thousand INR | -96.31% |
| 2022 Q1 | 10.23 Million INR | -63.9% |
| 2022 FY | - INR | -73.62% |
| 2022 Q2 | 25.06 Million INR | 145.03% |
| 2022 Q4 | 20.72 Million INR | 2142.75% |
| 2021 Q2 | 64.81 Million INR | 2.03% |
| 2021 Q1 | 63.52 Million INR | 27.77% |
| 2021 Q4 | 28.33 Million INR | -52.09% |
| 2021 FY | - INR | 122.85% |
| 2021 Q3 | 59.15 Million INR | -8.74% |
| 2020 FY | - INR | 195.95% |
| 2020 Q3 | 7.87 Million INR | -59.43% |
| 2020 Q2 | 19.41 Million INR | 42.21% |
| 2020 Q1 | 13.65 Million INR | -18.78% |
| 2020 Q4 | 49.72 Million INR | 531.2% |
| 2019 Q2 | 11.49 Million INR | 1401.36% |
| 2019 FY | - INR | -36.38% |
| 2019 Q4 | 16.8 Million INR | 745.1% |
| 2019 Q3 | 1.98 Million INR | -82.69% |
| 2019 Q1 | -883 Thousand INR | -106.09% |
| 2018 Q1 | 16.68 Million INR | 15.34% |
| 2018 FY | - INR | -20.79% |
| 2018 Q4 | 14.49 Million INR | 4667.43% |
| 2018 Q3 | 304 Thousand INR | -98.13% |
| 2018 Q2 | 16.25 Million INR | -2.57% |
| 2017 Q1 | 3.3 Million INR | -60.43% |
| 2017 Q4 | 14.46 Million INR | -15.22% |
| 2017 FY | - INR | 9.76% |
| 2017 Q3 | 17.05 Million INR | -36.42% |
| 2017 Q2 | 26.83 Million INR | 713.06% |
| 2016 Q1 | 14.16 Million INR | 1605.05% |
| 2016 FY | - INR | 7.1% |
| 2016 Q4 | 8.34 Million INR | -49.97% |
| 2016 Q3 | 16.66 Million INR | -15.96% |
| 2016 Q2 | 19.83 Million INR | 39.98% |
| 2015 FY | - INR | 10.11% |
| 2015 Q1 | 24.03 Million INR | 57.18% |
| 2015 Q2 | 14.18 Million INR | -41.0% |
| 2015 Q3 | 11.68 Million INR | -17.59% |
| 2015 Q4 | 831 Thousand INR | -92.89% |
| 2014 Q4 | 15.29 Million INR | 138.2% |
| 2014 Q1 | 13.1 Million INR | 909.92% |
| 2014 FY | - INR | 94.12% |
| 2014 Q2 | 18.13 Million INR | 38.42% |
| 2014 Q3 | 6.42 Million INR | -64.6% |
| 2013 Q1 | 9.66 Million INR | 7.88% |
| 2013 Q4 | -1.61 Million INR | -398.51% |
| 2013 Q2 | 17.26 Million INR | 78.67% |
| 2013 FY | - INR | -42.17% |
| 2013 Q3 | 542 Thousand INR | -96.86% |
| 2012 Q3 | 11.33 Million INR | -20.74% |
| 2012 Q1 | 10.1 Million INR | 1742.33% |
| 2012 FY | - INR | 179.27% |
| 2012 Q4 | 8.95 Million INR | -20.98% |
| 2012 Q2 | 14.3 Million INR | 41.47% |
| 2011 Q3 | 6.18 Million INR | 0.0% |
| 2011 FY | - INR | -76.8% |
| 2011 Q4 | 548.65 Thousand INR | -91.12% |
| 2010 FY | - INR | 30.65% |
| 2009 FY | - INR | 23.96% |
| 2008 FY | - INR | 67.05% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -3940.992% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -122.825% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 71.001% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 69.354% |
| Sunil Healthcare Limited | 93.07 Million INR | 72.269% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -56.266% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.345% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 117.088% |
| Patidar Buildcon Limited | -5.52 Million INR | 567.101% |
| Roopa Industries Limited | 55.7 Million INR | 53.66% |
| Smruthi Organics Limited | 120.31 Million INR | 78.546% |
| Trident Lifeline Limited | 102.69 Million INR | 74.865% |
| PANJON LTD. | 4.08 Million INR | -531.255% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 120.937% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -62.575% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 235.482% |
| Anuh Pharma Limited | 878.5 Million INR | 97.062% |
| Crestchem Limited | 30.33 Million INR | 14.908% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 338.602% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 5.079% |
| Tyche Industries Limited | 128.2 Million INR | 79.867% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 93.364% |
| Trimurthi Limited | -2.47 Million INR | 1141.432% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 88.083% |
| Norris Medicines Limited | -1.78 Million INR | 1546.743% |
| Zenlabs Ethica Limited | 27.09 Million INR | 4.739% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 93.329% |
| ANG Lifesciences India Limited | 90.66 Million INR | 71.529% |
| Parmax Pharma Limited | 22.93 Million INR | -12.532% |
| Veerhealth Care Limited | 15.99 Million INR | -61.375% |
| Deccan Health Care Limited | 37.5 Million INR | 31.179% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 89.845% |
| Lactose (India) Limited | 201.22 Million INR | 87.172% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 126.84% |
| Zenith Healthcare Limited | 4.98 Million INR | -417.482% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 70.528% |
| Bacil Pharma Limited | -569.32 Thousand INR | 4633.83% |
| PRAVEG LIMITED | 321.43 Million INR | 91.97% |
| Denis Chem Lab Limited | 224.84 Million INR | 88.52% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 95.772% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 93.169% |
| Colinz Laboratories Limited | 5.42 Million INR | -375.534% |
| Godavari Drugs Limited | 134.62 Million INR | 80.827% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 6457.635% |
| Zenotech Laboratories Limited | 172.64 Million INR | 85.049% |
| Panchsheel Organics Limited | 189.36 Million INR | 86.369% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 94.248% |
| Vivanza Biosciences Limited | 11.2 Million INR | -130.382% |
| Phaarmasia Limited | -1.58 Million INR | 1731.606% |
| Sastasundar Ventures Limited | -203.51 Million INR | 112.683% |
| Medi-Caps Limited | 4.77 Million INR | -441.019% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 1048.971% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 96.894% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 84.867% |
| Mercury Laboratories Limited | 101.18 Million INR | 74.491% |
| Gennex Laboratories Limited | 219.35 Million INR | 88.233% |
| BDH Industries Limited | 124.27 Million INR | 79.23% |
| Coral Laboratories Limited | 227.07 Million INR | 88.633% |
| Concord Drugs Limited | 40.52 Million INR | 36.298% |
| Bharat Parenterals Limited | 265.74 Million INR | 90.287% |
| Beryl Drugs Limited | 26.63 Million INR | 3.104% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 179.718% |
| Evoq Remedies Limited | 6.18 Million INR | -317.132% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 68.756% |
| Transchem Limited | 56.61 Million INR | 54.405% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -117.127% |
| Parnax Lab Limited | 243.59 Million INR | 89.404% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 42.389% |
| Kerala Ayurveda Limited | 70.78 Million INR | 63.536% |
| Cian Healthcare Limited | 122.56 Million INR | 78.94% |
| Trinity League India Limited | -26.25 Million INR | 198.32% |
| Syschem (India) Limited | 70.4 Million INR | 63.336% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 401.085% |
| Natural Capsules Limited | 219.9 Million INR | 88.262% |
| Auro Laboratories Limited | 121.73 Million INR | 78.797% |